Stockscreener 앱 받기
53.72
1.22%
0.65
시간 외 거래:
53.71
-0.010
-0.02%
전일 마감가:
$53.07
열려 있는:
$52.72
하루 거래량:
59,871
Relative Volume:
0.58
시가총액:
$229.97M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.15%
1개월 성능:
-6.48%
6개월 성능:
+15.38%
1년 성능:
+21.95%
1일 변동 폭
$52.72
$54.09
1주일 범위
$52.72
$54.52
52주 변동 폭
$35.22
$58.84
State Street Spdr S P Pharmaceuticals Etf Stock (XPH) Company Profile
명칭
State Street Spdr S P Pharmaceuticals Etf
전화
-
주소
-
Compare XPH vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XPH
State Street Spdr S P Pharmaceuticals Etf
|
53.72 | 229.97M | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
325.44 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
State Street Spdr S P 500 Etf Trust
|
659.80 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
660.93 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
263.35 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
593.02 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Pharmaceuticals Etf 주식(XPH)의 최신 뉴스
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
These 5 Undervalued ETFs Could Be Bargains Right Now - AOL.com
South Korea's $350B U.S. Investment Pledge: ETFs That Could Gain - TradingView
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress - Benzinga
Better S&P 500 ETF: State Street's SPY vs. Vanguard's VOO - The Motley Fool
Most and least shorted healthcare stocks with up to $2B market cap in February - Seeking Alpha
Best S&P 500 ETFs to Buy in 2026 - The Motley Fool
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
Stock Market Today: Dow Jones, S&P500, Nasdaq Futures Decline After SC Strikes Down Trump's Emergency Tariffs— NVO, MSTR, VNDA In Focus (UPDATED) - Benzinga
XPH’s 29% Run Looks Tempting, But The 5y Chart Is A Warning - AOL.com
State Street SPDR S&P Global Dividend ETF Holdings - Quiver Quantitative
Best Blue Chip ETFs to Buy in 2026 - The Motley Fool
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development - Stocktwits
PTC Therapeutics Faces Translarna Setback While Valuation Signals Potential Upside - simplywall.st
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
Why Vertex Pharmaceuticals (VRTX) Is Up 6.0% After Profit Rebound And Non-CF Pipeline UpdateAnd What's Next - simplywall.st
NATCO Pharma Limited Just Missed Revenue By 8.4%: Here's What Analysts Think Will Happen Next - simplywall.st
Most and least shorted healthcare stocks with up to $2B market cap - Seeking Alpha
Rohto Pharmaceutical Co.,Ltd. Just Beat EPS By 6.6%: Here's What Analysts Think Will Happen Next - simplywall.st
XLP vs. FTXG: The Clash of Consumer Staple ETFs - AOL.com
Zealand Pharma A/S (CPH:ZEAL) most popular amongst retail investors who own 46% of the shares, institutions hold 38% - simplywall.st
Arrowhead Pharmaceuticals (ARWR) Valuation Check After Earnings Jump And S&P Index Move - simplywall.st
SPDR's Aerospace & Defense ETF Took An Unusual Approach That Smoked The S&P 500 With 54% Run - 24/7 Wall St.
XPH Should I Buy - Intellectia AI
The top performing pharma and biotech stocks as group sees resurgence (PJP:NYSEARCA) - Seeking Alpha
Most and least shorted mid-to mega-cap healthcare stocks in January - Seeking Alpha
Should State Street SPDR S&P 600 Small Cap Growth ETF (SLYG) Be on Your Investing Radar? - Yahoo Finance
Analysts Expect Breakeven For Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) Before Long - simplywall.st
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now - The Motley Fool
Arrowhead Joins S&P 400 As Profitability Shifts Investor Focus - simplywall.st
Should You Invest in the State Street SPDR S&P Regional Banking ETF (KRE)? - Yahoo Finance
Is State Street SPDR S&P Regional Banking ETF (KRE) a Strong ETF Right Now? - Yahoo Finance
XLP Delivers Pure-Play Staples While IYK Adds Healthcare. Which Strategy Wins? - AOL.com
Is State Street SPDR S&P Capital Markets ETF (KCE) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Insurance ETF (KIE) a Strong ETF Right Now? - Yahoo Finance
The 10 Best Performing ETFs Over the Last 10 Years - YCharts
How Investors Are Reacting To ARS Pharmaceuticals (SPRY) Expanded EU Pediatric Nod For Needle-Free Anaphylaxis Treatment - simplywall.st
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a strong ETF right now? - MSN
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now? - sharewise.com
Pharma stocks are close to ‘breaking out.’ Earnings could set them free. - MSN
Pharma Stocks Are Close to Breaking Out. Earnings Could Set Them Free. - Barron's
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)? - sharewise.com
Invesco’s PXH ETF Jumped 38% as Emerging Markets Finally Heat Up - AOL.com
BBH: Mature Biotech Exposure, But Limited Growth Ahead (NASDAQ:BBH) - Seeking Alpha
5 Biggest Pharmaceutical ETFs for Investors in 2026 - Nasdaq
Pharma ETFs: Your Key to Diversification in the Pharmaceutical Sector - Investing News Network
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan - sharewise.com
XPH: Healthcare Dashboard For January (NYSEARCA:XPH) - Seeking Alpha
Trump Unveils 'Great Healthcare Plan,' Takes Aim At PBM 'Kickbacks' - Benzinga
5 Biggest Clean Energy ETFs in 2026 - Investing News Network
State Street Spdr S P Pharmaceuticals Etf (XPH) 재무 분석
State Street Spdr S P Pharmaceuticals Etf (XPH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.14%
0.24%
자본화:
|
볼륨(24시간):